Pharming Group Receives Accelerated Assessment in Europe for l...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LEIDEN, the Netherlands, August 1, 2022 /PRNewswire-AsiaNet/ -- EMA accelerated assessment allows a shorter review period for leniolisib from a standard 210 days to 150 daysPharming is on track to submit its Marketing Authorisation Application for leniolisib in H2 2022Pharming Group N.V. ("Pharming" or...
Authors: LATEST ASIANET NEWS RELEASES